Impact of bimekizumab and certolizumab pegol on efficacy, safety and osteoblastic activity in radiographic axial spondyloarthritis: results from a phase IIa, multicentre, randomised, double-blind, exploratory study with PET-CT imaging

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Therapeutic Advances in Musculoskeletal Disease

Topics

Medicine

Immunology

Internal Medicine

Rheumatology

Certolizumab Pegol

Show all topics

DOI

10.1177/1759720x241293944

License

CC-BY-NC